|
|
 Previous Article | Table of Contents | Next Article 
Blood, 1 March 2001, Vol. 97, No. 5, pp. 1321-1329
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
A permissive role for tumor necrosis factor in vascular
endothelial growth factor-induced vascular permeability
Matthias Clauss,
Cord Sunderkötter,
Baldur Sveinbjörnsson,
Stefan Hippenstiel,
Antje Willuweit,
Michael Marino,
Elvira Haas,
Rolf Seljelid,
Peter Scheurich,
Norbert Suttorp,
Matthias Grell, and
Werner Risau
From the Department of Molecular Cell Biology,
Max-Planck-Institute, Bad Nauheim, Germany; Institute of Experimental
Dermatology and Department of Dermatology, Wilhelms-University of
Münster, Münster, Germany; Department of Experimental
Pathology, University of Tromsø, Tromsø, Norway; Department of
Internal Medicine, Charité, Humboldt-University, Berlin, Germany;
Ludwig Institute for Cancer Research, New York, NY; Institute of Cell
Biology and Immunology, University of Stuttgart, Stuttgart, Germany;
and Merck KGaA, Biomed Fo/ONC, Darmstadt, Germany.
Vascular endothelial growth factor (VEGF) induces both
angiogenesis and an increase in vascular permeability, 2 processes that
are considered to be important for both tumor growth and the delivery
of drugs to the site of tumors. This study demonstrates that
transmembrane expression of tumor necrosis factor (tmTNF) is
up-regulated in the endothelium of a murine methylcholanthrene (meth
A)-induced sarcoma in comparison to the adjacent normal dermal
vasculature and is also present on cultivated human endothelial cells.
It is further shown that tmTNF is required for VEGF-mediated endothelial hyperpermeability in vitro and in vivo. This permissive activity of TNF appears to be selective, because anti-TNF antibodies ablated the VEGF-induced permeability but not proliferation of cultivated human endothelial cells. Furthermore, tnf
gene-deficient mice show no obvious defects in vascularization
and develop normally but failed to respond to administration of VEGF
with an increase in vascular permeability. Subsequent studies indicated
that the tmTNF and VEGF signaling pathways converge at the level of a
secondary messenger, the "stress-activated protein kinase-2"
(SAPK-2)/p38: (1) up-regulated endothelial expression of tmTNF resulted
in the continuous activation of SAPK-2/p38 in vitro, and (2) an
inhibitor of SAPK-2/p38 activation abolished the vascular permeability
activity of VEGF in vivo. In conclusion, the study's finding that
continuous autocrine signaling by tmTNF sensitizes endothelial cells to
respond to VEGF by increasing their vascular permeability provides new therapeutic concepts for manipulating vascular hyperpermeability.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. Huang, Y. Ding, W.-M. Luo, S. Bender, C.-N. Qian, E. Kort, Z.-F. Zhang, K. VandenBeldt, N. S. Duesbery, J. H. Resau, et al.
Inhibition of MAPK Kinase Signaling Pathways Suppressed Renal Cell Carcinoma Growth and Angiogenesis In vivo
Cancer Res.,
January 1, 2008;
68(1):
81 - 88.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. T. Stathopoulos, A. Kollintza, C. Moschos, I. Psallidas, T. P. Sherrill, E. N. Pitsinos, S. Vassiliou, M. Karatza, S. A. Papiris, D. Graf, et al.
Tumor Necrosis Factor-{alpha} Promotes Malignant Pleural Effusion
Cancer Res.,
October 15, 2007;
67(20):
9825 - 9834.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Rajashekhar, M. Grow, A. Willuweit, C. E. Patterson, and M. Clauss
Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation
Physiol Genomics,
September 11, 2007;
31(1):
104 - 113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Murnaghan, G. Li, and D. R. Marsh
Nonsteroidal Anti-Inflammatory Drug-Induced Fracture Nonunion: An Inhibition of Angiogenesis?
J. Bone Joint Surg. Am.,
November 1, 2006;
88(suppl_3):
140 - 147.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Malik, K. Day, I. Perrault, D.S. Charnock-Jones, and S. K. Smith
Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-{alpha} in menstrual endometrium and effluent in women with menorrhagia
Hum. Reprod.,
August 1, 2006;
21(8):
2158 - 2166.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. K. Mullarky, F. M. Szaba, K. N. Berggren, L. W. Kummer, L. B. Wilhelm, M. A. Parent, L. L. Johnson, and S. T. Smiley
Tumor Necrosis Factor Alpha and Gamma Interferon, but Not Hemorrhage or Pathogen Burden, Dictate Levels of Protective Fibrin Deposition during Infection
Infect. Immun.,
February 1, 2006;
74(2):
1181 - 1188.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. B. El-Remessy, M. Al-Shabrawey, Y. Khalifa, N.-T. Tsai, R. B. Caldwell, and G. I. Liou
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
Am. J. Pathol.,
January 1, 2006;
168(1):
235 - 244.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cattaruzza, T. J. Guzik, W. Slodowski, A. Pelvan, J. Becker, M. Halle, A. B. Buchwald, K. M. Channon, and M. Hecker
Shear Stress Insensitivity of Endothelial Nitric Oxide Synthase Expression as a Genetic Risk Factor for Coronary Heart Disease
Circ. Res.,
October 15, 2004;
95(8):
841 - 847.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Gustin, R. Pincheira, L. D. Mayo, O. N. Ozes, K. M. Kessler, M. R. Baerwald, C. K. Korgaonkar, and D. B. Donner
Tumor necrosis factor activates CRE-binding protein through a p38 MAPK/MSK1 signaling pathway in endothelial cells
Am J Physiol Cell Physiol,
March 1, 2004;
286(3):
C547 - C555.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-y. Liu, Y.-q. Wei, L. Yang, X. Zhao, L. Tian, J.-m. Hou, T. Niu, F. Liu, Y. Jiang, B. Hu, et al.
Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2
Blood,
September 1, 2003;
102(5):
1815 - 1823.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Petrache, A. Birukova, S. I. Ramirez, J. G. N. Garcia, and A. D. Verin
The Role of the Microtubules in Tumor Necrosis Factor-{alpha}-Induced Endothelial Cell Permeability
Am. J. Respir. Cell Mol. Biol.,
May 1, 2003;
28(5):
574 - 581.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Wherry, J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed
Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment
J. Virol.,
April 15, 2003;
77(8):
4911 - 4927.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.-M. Khatib, L. Fallavollita, E. V. Wancewicz, B. P. Monia, and P. Brodt
Inhibition of Hepatic Endothelial E-Selectin Expression by C-raf Antisense Oligonucleotides Blocks Colorectal Carcinoma Liver Metastasis
Cancer Res.,
October 1, 2002;
62(19):
5393 - 5398.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Blain, I. Abdelmouttaleb, J. Belmin, A. Blain, J. Floquet, J.-L. Gueant, and C. Jeandel
Arterial Wall Production of Cytokines in Giant Cell Arteritis: Results of a Pilot Study Using Human Temporal Artery Cultures
J. Gerontol. A Biol. Sci. Med. Sci.,
April 1, 2002;
57(4):
M241 - 245.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Becker, A. D. Verin, M. A. Booth, F. Liu, A. Birukova, and J. G. N. Garcia
Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells
Am J Physiol Lung Cell Mol Physiol,
December 1, 2001;
281(6):
L1500 - L1511.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Willuweit, G. Sass, A. Schoneberg, U. Eisel, G. Tiegs, and M. Clauss
Chronic Inflammation and Protection from Acute Hepatitis in Transgenic Mice Expressing TNF in Endothelial Cells
J. Immunol.,
October 1, 2001;
167(7):
3944 - 3952.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Beauregard, S. A. Hill, D. J. Chaplin, and K. M. Brindle
The Susceptibility of Tumors to the Antivascular Drug Combretastatin A4 Phosphate Correlates with Vascular Permeability
Cancer Res.,
September 1, 2001;
61(18):
6811 - 6815.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
